Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,030.00. The ...

Libtayo became Regeneron's latest blockbuster ... maximize the growth opportunities from our in-line brands, initiate a quarterly dividend, and significantly increase our capacity to repurchase ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

Libtayo sales are being driven by growth in ... The drug has been approved under the brand name Ordspono. Investors will also look for key pipeline updates from Regeneron apart from the top ...

WeCook, Canada's premier ready-to-eat meal delivery service, is proud to announce hockey icon and beloved personality P.K.

Fast-casual Ohio-based US restaurant brand City BBQ has formed a partnership with customer data platform Bikky to drive ...

Languages: English, Italian People are increasingly careful about where they spend their money, and they want to be sure the brands they choose will provide quality products at fair prices and a ...

Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...

Taking control of your brand can mean the difference between an unfulfilling job and a rewarding career. But how can you persuade others to take the reinvented you seriously? The author presents a ...

A ~$4.5B share repurchase program adds further value. LIBTAYO demonstrated massive growth, accelerating to 50% in Q4 2024 versus Q4 2023. Approval in CSCC means that this growth catalyst is ...